Ning Lin

Dr. Ning Lin


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2017 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
HSHongyu Sun
Hongyu Sun
JZJing Zhou
Jing Zhou
ZHZhu Huang
Zhu Huang
LQLinlin Qu
Linlin Qu
NLNing Lin
Ning Lin
FTFuzhou Tian
Fuzhou Tian
Carbon nanotubes (CNTs) provide an essential 2-D microenvironment for cardiomyocyte growth and function. However, it remains to be elucidated whether CNT nanostructures can promote cell–cell integrity and facilitate the formation of functional tissues in 3-D hydrogels. Here, single-walled CNTs were incorporated into collagen hydrogels to fabricate (CNT/Col) hydrogels, which improved mechanical and electrical properties. The incorporation of CNTs (up to 1 wt%) exhibited no toxicity to cardiomyocytes and enhanced cell adhesion and elongation. Through the use of immunohistochemical staining, transmission electron microscopy, and intracellular calcium-transient measurement, the incorporation of CNTs was found to improve cell alignment and assembly remarkably, which led to the formation of engineered cardiac tissues with stronger contraction potential. Importantly, cardiac tissues based on CNT/Col hydrogels were noted to have better functionality. Collectively, the incorporation of CNTs into the Col hydrogels improved cell alignment and the performance of cardiac constructs. Our study suggests that CNT/Col hydrogels offer a promising tissue scaffold for cardiac constructs, and might serve as injectable biomaterials to deliver cell or drug molecules for cardiac regeneration following myocardial infarction in the near future.

8 January 2013 in Nutrition Journal
Verified
Journal Article
Open access
PDF file
WZWei Zhu
Wei Zhu
DCDonglian Cai
Donglian Cai
YWYing Wang
Ying Wang
NLNing Lin
Ning Lin
QHQingqing Hu
Qingqing Hu
SASidath Amarasekara
Sidath Amarasekara
Background: Recent evidence suggests that higher calcium and/or vitamin D intake may be associated with lower body weight and better metabolic health. Due to contradictory findings from intervention trials, we investigated the effect of calcium plus vitamin D3 (calcium+D) supplementation on anthropometric and metabolic profiles during energy restriction in healthy, overweight and obese adults with very-low calcium consumption. Methods: Fifty-three subjects were randomly assigned in an open-label, randomized controlled trial to receive either an energy-restricted diet (−500 kcal/d) supplemented with 600 mg elemental calcium and 125 IU vitamin D3 or energy restriction alone for 12 weeks. Repeated measurements of variance were performed to evaluate the differences between groups for changes in body weight, BMI, body composition, waist circumference, and blood pressures, as well as in plasma TG, TC, HDL, LDL, glucose and insulin concentrations. Results: Eighty-one percent of participants completed the trial (85% from the calcium + D group; 78% from the control group). A significantly greater decrease in fat mass loss was observed in the calcium + D group (−2.8±1.3 vs.-1.8±1.3 kg; P=0.02) than in the control group, although there was no significant difference in body weight change (P>0.05) between groups. The calcium + D group also exhibited greater decrease in visceral fat mass and visceral fat area (P0.05). Conclusion: Calcium plus vitamin D3 supplementation for 12 weeks augmented body fat and visceral fat loss in very-low calcium consumers during energy restriction. Trial registration: ClinicalTrials.gov (NCT01447433, http://clinicaltrials.gov/).

1 January 2017 in Acta Biomaterialia
Verified
Journal Article
Closed access
HSHongyu Sun
Hongyu Sun
JTJiajia Tang
Jiajia Tang
YMYongchao Mou
Yongchao Mou
JZJing Zhou
Jing Zhou
LQLinlin Qu
Linlin Qu
FTFuzhou Tian
Fuzhou Tian

20 August 2016 in Lipids in Health and Disease
Verified
Journal Article
Open access
PDF file
NLNing Lin
Ning Lin
JSJiao-Jiao Shi
Jiao-Jiao Shi
YLYunming Li
Yunming Li
XZXin-Yan Zhang
Xin-Yan Zhang
YCYi Chen
Yi Chen
LTLi-Jun Tang
Li-Jun Tang
To explore the possible role of n-3 polyunsaturated fatty acids (PUFAs) in lowering inflammation markers in individuals with type 2 diabetes mellitus. PubMed, CNKI and Cochrane databases were searched until December 30, 2015; references from papers or reviews were also retrieved and screened. Screening was performed by two independent researchers, and randomized controlled trials reporting the specific n-3 PUFA type, dose, frequency, and duration of treatment, as well as the baseline and follow-up concentrations of inflammation markers, including interleukin 2 (IL-2), interleukin 6 (IL-6), tumor necrosis factor alpha (TNF-α) and C-reactive protein (CRP), were selected for final analysis. Data analysis was performed using RevMan 5.2 software. Eight studies involving 955 participants were included; all reported CRP. Only one included study reported IL-2 or IL-6 while two studies reported TNF-α. N-3 PUFAs significantly reduced CRP concentration compared with control [SMD 95 % CI, 1.90 (0.64, 3.16), Z = 2.96, P = 0.003, random effect model]. N-3 PUFAs decrease CRP concentration in type-2 diabetes mellitus. However, larger and rigorously designed RCTs are required to confirm this finding and extend it into other inflammatory biomarkers.

19 March 2013 in Molecular Nutrition & Food Research
Verified
Journal Article
Closed access
PDF file
NLNing Lin
Ning Lin
YLYunming Li
Yunming Li
LTLijun Tang
Lijun Tang
JSJiaojiao Shi
Jiaojiao Shi
YCYi Chen
Yi Chen

4 June 2013 in Cell Biochemistry and Biophysics
Verified
Journal Article
Closed access
PDF file
NLNing Lin
Ning Lin
DCDong-Lian Cai
Dong-Lian Cai
DJDi Jin
Di Jin
YCYi Chen
Yi Chen
JSJiao-Jiao Shi
Jiao-Jiao Shi